[1] |
BURRAI G P, GABRIELI A, MOCCIA V, et al. A statistical analysis of risk factors and biological behavior in canine mammary tumors:A multicenter study[J]. Animals (Basel), 2020, 10(9):1687.
|
[2] |
ROWELL J L, MCCARTHY D O, ALVAREZ C E. Dog models of naturally occurring cancer[J]. Trends Mol Med, 2011, 17(7):380-388.
|
[3] |
VALDIVIA G, ALONSO-DIEZ Á, PÉREZ-ALENZA D, et al. From conventional to precision therapy in canine mammary cancer:A comprehensive review[J/OL]. Front Vet Sci, 2021, 8:623800.[2022-12-28]. https://www.frontiersin.org/articles/10.3389/fvets.2021.623800/full.
|
[4] |
PETROUŠKOVÁ P, HUDÁKOVÁ N, MALOVESKÁ M, et al. Non-exosomal and exosome-derived miRNAs as promising biomarkers in canine mammary cancer[J]. Life (Basel), 2022, 12(4):524.
|
[5] |
BOGGS R M, WRIGHT Z M, STICKNEY M J, et al. MicroRNA expression in canine mammary cancer[J]. Mamm Genome, 2008, 19(7-8):561-569.
|
[6] |
任晓丽, 常宏建, 赵冰冰, 等. microRNA在乳腺肿瘤诊断中的研究进展[J]. 动物医学进展, 2018, 39(4):76-82.REN X L, CHANG H J, ZHAO B B, et al. Progress on miRNA in breast tumor diagnosis[J]. Progress in Veterinary Medicine, 2018, 39(4):76-82. (in Chinese)
|
[7] |
任晓丽, 范玉营, 石冬梅, 等. miR-502在犬乳腺癌中的表达及意义[J]. 畜牧兽医学报, 2020, 51(1):193-197.REN X L, FAN Y Y, SHI D M, et al. Expressions of miR-502 in canine breast cancer and clinical significance[J]. Acta Veterinaria et Zootechnica Sinica, 2020, 51(1):193-197.
|
[8] |
OSAKI T, SUNDEN Y, SUGIYAMA A, et al. Establishment of a canine mammary gland tumor cell line and characterization of its miRNA expression[J]. J Vet Sci, 2016, 17(3):385-390.
|
[9] |
IIDA M, TAIRA T, ARIGA H, et al. Induction of apoptosis in HeLa cells by MSSP, c-myc binding proteins[J]. Biol Pharm Bull, 1997, 20(1):10-14.
|
[10] |
ZHANG W, SUN Y, BAI L, et al. RBMS1 regulates lung cancer ferroptosis through translational control of SLC7A11[J]. J Clin Invest, 2021, 131(22):e152067.
|
[11] |
DANKERT J T, WIESEHÖFER M, WACH S, et al. Loss of RBMS1 as a regulatory target of miR-106b influences cell growth, gap closing and colony forming in prostate carcinoma[J]. Sci Rep, 2020, 10(1):18022.
|
[12] |
DESANTIS C E, MA J, GAUDET M M, et al. Breast cancer statistics, 2019[J]. CA Cancer J Clin, 2019, 69(6):438-451.
|
[13] |
GRAY M, MEEHAN J, MARTÍNEZ-PÉREZ C, et al. Naturally-occurring canine mammary tumors as a translational model for human breast cancer[J/OL]. Front Oncol, 2020, 10:617.[2022-12-28]. https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.00617/full.
|
[14] |
ABDELMEGEED S M, MOHAMMED S. Canine mammary tumors as a model for human disease[J]. Oncol Lett. 2018, 15(6):8195-8205.
|
[15] |
SAHABI K, SELVARAJAH G T, ABDULLAH R, et al. Comparative aspects of microRNA expression in canine and human cancers[J]. J Vet Sci, 2018, 19(2):162-171.
|
[16] |
REN X L, FAN Y Y, SHI D M, et al. MicroRNA-124 inhibits canine mammary carcinoma cell proliferation, migration and invasion by targeting CDH2[J]. Res Vet Sci, 2022, 146:5-14.
|
[17] |
ZHANG T, FENG X, ZHOU T, et al. miR-497 induces apoptosis by the IRAK2/NF-κB axis in the canine mammary tumour[J]. Vet Comp Oncol, 2021, 19(1):69-78.
|
[18] |
XU J, PAN X, HU Z. miR-502 mediates esophageal cancer cell TE1 proliferation by promoting AKT phosphorylation[J]. Biochem Biophys Res Commun, 2018, 501(1):119-123.
|
[19] |
HUANG C, WANG Q, MA S, et al. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma[J]. Int J Clin Oncol, 2019, 24(8):976-982.
|
[20] |
LIU B, ZHANG X, SONG F, et al. miR-502/SET8 regulatory circuit in pathobiology of breast cancer[J]. Cancer Lett, 2016, 376(2):259-267.
|
[21] |
YING Y, LI J, XIE H, et al. CCND1, NOP14 and DNMT3B are involved in miR-502-5p-mediated inhibition of cell migration and proliferation in bladder cancer[J]. Cell Prolif, 2020, 53(2):e12751.
|
[22] |
YU J, NAVICKAS A, ASGHARIAN H, et al. RBMS1 suppresses colon cancer metastasis through targeted stabilization of its mRNA regulon[J]. Cancer Discov, 2020, 10(9):1410-1423.
|
[23] |
YIN M, Lü M, YAO G, et al. Transactivation of microRNA-383 by steroidogenic factor-1 promotes estradiol release from mouse ovarian granulosa cells by targeting RBMS1[J]. Mol Endocrinol, 2012, 26(7):1129-1143.
|